SCHEMBL28042565

SCHEMBL28042565

COCCc1c(N)nc(-n2cccn2)nc1N

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 17/20 0.50
ADORA3 P0DMS8 1/20 0.50
ADORA2B P29275 1/20 0.50
ADORA1 P30542 1/20 0.50
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
PDE10A Q9Y233 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2549250 0.83 ADORA2A (0.56) ADORA2AADORA3ADORA2BADORA1LMNA
SCHEMBL29800890 0.80 ADORA2A (0.41) ADORA2AADORA3ADORA2BADORA1LMNA
SCHEMBL2553742 0.80 ADORA2A (0.58) ADORA2AADORA3ADORA2BADORA1LMNA
SCHEMBL28042501 0.77 PDE10A (0.46) ADORA2AADORA1LMNAPDE10AKDM4E
SCHEMBL29800865 0.75 ADORA2A (0.40) ADORA2AADORA3ADORA2BADORA1
SCHEMBL15905323 0.75 ADORA2A (0.64) ADORA2AADORA3ADORA2BADORA1PDE10A
SCHEMBL2550277 0.74 ADORA2A (0.62) ADORA2AADORA3ADORA2BADORA1LMNA
SCHEMBL2550404 0.73 ADORA2A (0.53) ADORA2AADORA3ADORA2BADORA1LMNA
SCHEMBL2547816 0.72 ADORA2A (0.80) ADORA2AADORA3ADORA2BADORA1LMNA
SCHEMBL2541912 0.72 ADORA2A (0.59) ADORA2AADORA3ADORA2BADORA1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105008346-A Novel pyrimidine derivatives as phosphodiesterase 10(PDE-10) inhibitors PALOBIOFARMA SL 2015-10-28 CN claimed
CN-105008346-A Novel pyrimidine derivatives as phosphodiesterase 10(PDE-10) inhibitors PALOBIOFARMA SL 2015-10-28 CN disclosed